Navigation Links
North American Drug Delivery Technologies Market Report - Forecasts to 2017
Date:8/6/2013

DUBLIN, August 6, 2013 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/7ldcr3/north_american) have announced the addition of the "North American Drug Delivery Technologies Market - Forecasts To 2017" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The North American drug delivery market was estimated to be worth $66.7 billion in 2012, and is expected to register a CAGR of 8.9% between 2012 and 2017

'North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017'

This research report categorizes and analyzes the North American Drug Delivery Technologies market on the basis of routes of administration. These markets are further divided into segments and sub-segments, to provide exhaustive value analysis for the years 2010, 2011, 2012, and forecast to 2017. Each market is comprehensively analyzed at a granular level by country (U.S and Canada), to provide in-depth information on the North American market scenario.

The patent expiry of major blockbuster drugs is a prime concern for pharmaceutical companies, as developing a new chemical entity (NCE) is more expensive and time consuming than a novel drug delivery technology. Therefore, in recent years, several pharmaceutical companies have employed drug delivery technology as a life cycle management tool for some of their blockbuster drugs, the patents for which are set to expire in the near future.

Based on the route of administration, the drug delivery market has been classified as oral, pulmonary, injectable, transdermal, implantable, ocular, nasal, transmucosal, and topical. In 2012, oral drug delivery segment dominated the market with a share of approximately 38%, followed by pulmonary drug delivery segment with a 20% share.

The drug delivery technologies that have recently gained importance in the North American market include orodispersible tablet (ODT), dry powder inhalers, transdermal patches, needle-free injectors, auto and pen injectors, and buccal transmucosal tablets; controlled release is the most widely accepted technology. The use of implantable devices for drug delivery is also on a rise.

Big pharmaceutical companies such as Pfizer and Merck have established in-house capabilities for the development of drug delivery technologies. On the other hand, many companies are still relying on specialty companies engaged in the development of drug delivery technologies. A high level of competition and increasing need for outsourcing has resulted in the fragmentation of the drug delivery market, with several small companies developing novel drug delivery technologies for niche therapeutic applications.

The North American drug delivery market is largely dominated by the U.S. (accounting for about 89% of the overall market). The key drivers for the U.S. drug delivery market are the well established pharmaceutical industry, healthcare reforms, and favourable changes in the FDA review process. Factors such as low cost drug manufacturing and a rising number of drug delivery formulations and devices are propelling the Canadian market.

Key Topics Covered:

1 Introduction
2 Executive Summary
3 Market Overview

4 North America Drug Delivery Market, By Technology
4.1 Introduction
4.2 Opportunity Matrix
4.3 Oral Drug Delivery
4.4 Pulmonary Drug Delivery
4.5 Transdermal Drug Delivery
4.6 Injectable Drug Delivery
4.7 Ocular Drug Delivery
4.8 Nasal Drug Delivery
4.9 Topical Drug Delivery
4.10 Implantable Drug Delivery
4.11 Transmucosal Drug Delivery

5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*

- Aptalis Pharma, Inc
- Baxter International, Inc
- Becton, Dickinson And Company
- Catalent Pharma Solutions
- Cima Labs
- Endo Health Solutions, Inc
- Johnson & Johnson, Inc
- M Company
- Nektar Therapeutics, Inc
- Optinose As
- Psivida Corporation
- The Dow Chemical Company
- Valeant Pharmaceuticals

For more information visit http://www.researchandmarkets.com/research/7ldcr3/north_american

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biotechnology


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Elekta, pioneer in treatment of cancer in brain disorders, to Move North America Headquarters to Atlanta
2. Northwest Bio Awarded $5.5 Million German Government Grant
3. Hill-Rom Appoints Alton Shader President of Hill-Rom North America
4. Instrumentation Laboratory Now Distributing Hemostasis Product Line In North America
5. HealthWarehouse.com and Northwest Physicians Network Partner to Provide Exclusive Discount Pharmacy Services to Patients
6. North America ENT Devices Market Outlook to 2018 - Diagnostic Devices, Hearing Aid Devices, Hearing Implants and Others
7. Analysis of the North American Radiology Image and Information Management Systems Market
8. North Dakotas Stop-Sale System Achieves Significant Results In Battle Against Meth
9. Somnetics Pioneering CPAP Device Receives the 2012 North American Frost & Sullivan Award for Product Differentiation Excellence
10. North America Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others
11. Astellas to Close Urogenix, North Carolina-based Urology Research Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... , Aug. 23, 2017 DarioHealth Corp. ... with mobile health and big data solutions, announced ... placement offerings with domestic and non-U.S. investors for ... stock and shares of the Company,s newly designated ... placement offerings. Current shareholders accounted for 58% of ...
(Date:8/17/2017)... MJAC2017 , the premier cannabis event devoted to retail ... leading lineup. MJAC2017 is proud to ... in the development of pharmaceutical and consumer products, will be ... Green Organic Dutchman are gold sponsors for the event, joined ... ...
(Date:8/15/2017)...   Mostyn Law and Gulf Coast Regional Blood Center ... . The Mostyn Law family has had 3 members ... why Mostyn Law is partnering with Gulf Coast Regional ... appreciation. Blood supplies are running low. Gulf Coast Regional ... needs in August. That is why the blood center reached out ...
Breaking Medicine Technology:
(Date:8/23/2017)... ... August 23, 2017 , ... Silicon Valley Hair Institute, a leading ... archive organized month-by-month. The new rotation of archived blog posts can provide a wide ... information about hair transplantation can review details online and then reach out for a ...
(Date:8/23/2017)... ... August 23, 2017 , ... ... American Academy of Orthopaedic Surgeons , points out that therapeutic modalities (physical therapy) ... or injury. According to the report, a wider scope of physical therapy options ...
(Date:8/22/2017)... , ... August 22, 2017 , ... The Women’s Choice ... awarded Zyclear Migraine Relief with the 2017 Women’s Choice Award. The identification by women ... that 3 out of 4 migraine sufferers are women. In a survey taken by ...
(Date:8/22/2017)... ... August 22, 2017 , ... ... to announce the addition of Zack Tisch as the firm’s new Consulting Services ... healthcare IT consulting firm’s national accounts, from assisting clients with initial vendor selection ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... Nurses at ... acres at picturesque Babcock Cove, recently received training and certification in Closed Pulse ... which has a prestigious five-star rating from the Centers for Medicare and Medicaid Services, ...
Breaking Medicine News(10 mins):